Zobrazeno 1 - 10
of 120
pro vyhledávání: '"R. Ferriols Lisart"'
Autor:
C, Ezquer-Garin, R, Ferriols-Lisart, L M, Martinez-López, C, Sangrador-Pelluz, J, Nicolás-Picó, M, Alós-Almiñana
Publikováno v:
Die Pharmazie. 75(5)
This is a report on the chemical stability and physical compatibility of intravenous tedizolid phosphate 0.8 mg/mL-sodium rifampicin 2.4 mg/mL and tedizolid phosphate 0.8 mg/mL-meropenem 4 mg/mL combinations in polypropylene 0.9% sodium chloride infu
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carlos Ezquer-Garin, Laura Escuder-Gilabert, R. Ferriols Lisart, Yolanda Martín-Biosca, Salvador Sagrado, M.J. Medina-Hernández
Publikováno v:
TALANTA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
In this paper, a simple, rapid and sensitive method based on liquid chromatography with fluorimetric detection (HPLC-FLD) for the determination of amikacin (AMK) in human plasma is developed. Determination is performed by pre-column derivatization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9adc7a0a26643964a01edc3601d432e8
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3135
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3135
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:256-259
Objective To assess the technique employed by the autoanalyser Architect® i1000 sr to determine digoxin in serum samples, compared with the assay developed for AsSYM® using microparticle enzyme immunoassay (Digoxin II). Method A prospective analysi
Publikováno v:
Farmacia Hospitalaria. 35:256-259
Objective: To assess the technique employed by the autoanalyser Architect® i1000 sr to determine digoxin in serum samples, compared with the assay developed for AsSYM® using microparticle enzyme immunoassay (DigoxinII). Method: A prospective analys
Autor:
R. Ferriols Lisart, D. Ayago Flores
Publikováno v:
Farmacia Hospitalaria. 34:163-169
Objective: To assess the effectiveness of palifermin for the prevention of oral mucositis in patients with haematological cancers. Methods: Retrospective observational study of cohorts of patients with haematological cancer undergoing cytotoxic thera
Autor:
D. Ayago Flores, R. Ferriols Lisart
Publikováno v:
Farmacia Hospitalaria (English Edition). 34:163-169
Objective To assess the effectiveness of palifermin for the prevention of oral mucositis in patients with haematological cancers. Method Retrospective observational study of cohorts of patients with haematological cancer undergoing cytotoxic therapy
Autor:
A. Clopés Estela, M.J. Otero López, M.D. Guerrero Aznar, J.P. Ordovás Baines, M.J. Martínez Bengoechea, R. Ferriols Lisart, B. Santos Ramos, S. Artacho Criado
Publikováno v:
Farmacia Hospitalaria. 31:137-140
Autor:
D, Ayago Flores, R, Ferriols Lisart
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 34(4)
To assess the effectiveness of palifermin for the prevention of oral mucositis in patients with haematological cancers.Retrospective observational study of cohorts of patients with haematological cancer undergoing cytotoxic therapy causing hematopoie
Publikováno v:
Anales de pediatria (Barcelona, Spain : 2003). 68(2)
Inappropriate use of vancomycin contributes to the development of resistant bacteria and jeopardizes the safety and effectiveness of treatment. The aim of this article was to design and validate an empirical dosing algorithm for vancomycin in prematu